NCT06336148 2025-10-15A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsActym Therapeutics, Inc.Phase 1 Terminated10 enrolled
NCT04234113 2025-01-08Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled
NCT03127098 2024-08-06QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerNantCell, Inc.Phase 1/2 Terminated3 enrolled 6 charts
NCT04190628 2024-05-21Safety and Tolerability of ABM-1310 in Patients With Advanced Solid TumorsABM Therapeutics CorporationPhase 1 Terminated53 enrolled
NCT02628535 2022-02-08Safety Study of MGD009 in B7-H3-expressing TumorsMacroGenicsPhase 1 Terminated67 enrolled
NCT00689065 2013-11-01Safety Study of CALAA-01 to Treat Solid Tumor CancersCalando PharmaceuticalsPhase 1 Terminated24 enrolled